Dapiprazole

CHEMBL1201216 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
325.5 g/mol
LogP
2.4
Phase
4

An alpha-adrenergic blocker used as eye drops to reverse pharmacologically dilated pupils after ophthalmic examinations by constricting the iris sphincter muscle. It provides a faster return to normal pupil size compared to simply waiting for the dilation to wear off. Side effects include eye redness, burning, and stinging.

น้ำหนักโมเลกุล

325.5000 g/mol

LogP

2.40

TPSA

37.20 Ų

Lipinski RO5

ผ่าน

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1

InChI

InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3

Molecular Formula

C19H27N5

HBD / HBA

- / 4

พันธะที่หมุนได้

4

อะตอมหนัก

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An alpha-adrenergic blocker used as eye drops to reverse pharmacologically dilated pupils after ophthalmic examinations by constricting the iris sphincter muscle. It provides a faster return to normal pupil size compared to simply waiting for the dilation to wear off. Side effects include eye redness, burning, and stinging.

Yes, Dapiprazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201216. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3033538. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.